Suchergebnisse - "Xin, Qianqian"

PubPharm (47)

1

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile

enthalten in: Vaccines | 2023

von Le Corre, N. | Abarca, K. | Astudillo, P. | +28

2

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer

enthalten in: Investigational new drugs | 2023

von Yang, Y. | Zheng, Q. | Wang, X. | +9

3

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer

enthalten in: Investigational new drugs | 2023

von Yang, Y. | Zheng, Q. | Wang, X. | +9

4

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer

enthalten in: Investigational new drugs | 2023

von Yang, Y. | Zheng, Q. | Wang, X. | +9

5

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer

enthalten in: Investigational new drugs | 2023

von Yang, Y. | Zheng, Q. | Wang, X. | +9

6

Association of adenosine triphosphate-related genes to major depression and suicidal behavior : Cognition as a potential mediator

enthalten in: Journal of affective disorders | 2023

von Zheng, S. | Guo, J. | Xin, Q. | +8

7

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children

enthalten in: mBio | 2022

von Soto, J. | Melo-González, F. | Gutierrez-Vera, C. | +54

8

Can cognition help predict suicide risk in patients with major depressive disorder? A machine learning study

enthalten in: BMC psychiatry | 2022

von Zheng, S. | Zeng, W. | Xin, Q. | +7

9

Can cognition help predict suicide risk in patients with major depressive disorder? A machine learning study

enthalten in: BMC psychiatry | 2022

von Zheng, S. | Zeng, W. | Xin, Q. | +7

10

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials

enthalten in: Nature communications | 2022

von Xin, Q. | Wu, Q. | Chen, X. | +12

1
2
3
4
5
Nächster »
[5]